$820,319
-2.8%
Chief MED Officer THRU 6/24
2024
$716k org
20 hrs/wk
$106k other
--
Chief MED Officer THRU 6/24 at Parker Institute for Cancer Immunotherapy
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Ute Dugan, M.D. has been listed as an employee of Parker Institute for Cancer Immunotherapy in Form 990 filings since fiscal year 2021. Total compensation for Ute Dugan, M.D. has increased by 3.6% from 2021 to 2024.